Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design

IF 15.2 1区 医学 Q1 PHARMACOLOGY & PHARMACY Advanced drug delivery reviews Pub Date : 2024-04-02 DOI:10.1016/j.addr.2024.115301
Neil Mathias , Sylvain Huille , Marie Picci , Robert P. Mahoney , Ronald J. Pettis , Brian Case , Bernhard Helk , David Kang , Ronak Shah , Junchi Ma , Deep Bhattacharya , Yogita Krishnamachari , Dany Doucet , Nathalie Maksimovikj , Sahab Babaee , Patrick Garidel , Reza Esfandiary , Rajesh Gandhi
{"title":"Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design","authors":"Neil Mathias ,&nbsp;Sylvain Huille ,&nbsp;Marie Picci ,&nbsp;Robert P. Mahoney ,&nbsp;Ronald J. Pettis ,&nbsp;Brian Case ,&nbsp;Bernhard Helk ,&nbsp;David Kang ,&nbsp;Ronak Shah ,&nbsp;Junchi Ma ,&nbsp;Deep Bhattacharya ,&nbsp;Yogita Krishnamachari ,&nbsp;Dany Doucet ,&nbsp;Nathalie Maksimovikj ,&nbsp;Sahab Babaee ,&nbsp;Patrick Garidel ,&nbsp;Reza Esfandiary ,&nbsp;Rajesh Gandhi","doi":"10.1016/j.addr.2024.115301","DOIUrl":null,"url":null,"abstract":"<div><p>Subcutaneous (SC) injections can be associated with local pain and discomfort that is subjective and may affect treatment adherence and overall patient experience. With innovations increasingly focused on finding ways to deliver higher doses and volumes (≥2 mL), there is a need to better understand the multiple intertwined factors that influence pain upon SC injection. As a priority for the SC Drug Development &amp; Delivery Consortium, this manuscript provides a comprehensive review of known attributes from published literature that contribute to pain/discomfort upon SC injection from three perspectives: (1) device and delivery factors that cause physical pain, (2) formulation factors that trigger pain responses, and (3) human factors impacting pain perception. Leveraging the Consortium’s collective expertise, we provide an assessment of the comparative and interdependent factors likely to impact SC injection pain. In addition, we offer expert insights and future perspectives to fill identified gaps in knowledge to help advance the development of patient-centric and well tolerated high-dose/high-volume SC drug delivery solutions.</p></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":null,"pages":null},"PeriodicalIF":15.2000,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced drug delivery reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169409X24001236","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Subcutaneous (SC) injections can be associated with local pain and discomfort that is subjective and may affect treatment adherence and overall patient experience. With innovations increasingly focused on finding ways to deliver higher doses and volumes (≥2 mL), there is a need to better understand the multiple intertwined factors that influence pain upon SC injection. As a priority for the SC Drug Development & Delivery Consortium, this manuscript provides a comprehensive review of known attributes from published literature that contribute to pain/discomfort upon SC injection from three perspectives: (1) device and delivery factors that cause physical pain, (2) formulation factors that trigger pain responses, and (3) human factors impacting pain perception. Leveraging the Consortium’s collective expertise, we provide an assessment of the comparative and interdependent factors likely to impact SC injection pain. In addition, we offer expert insights and future perspectives to fill identified gaps in knowledge to help advance the development of patient-centric and well tolerated high-dose/high-volume SC drug delivery solutions.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
实现更耐受的皮下注射:回顾改进组合产品设计的有利因素
皮下注射(SC)可能会引起局部疼痛和不适,这种主观疼痛和不适可能会影响治疗的依从性和患者的整体体验。随着创新越来越多地集中于寻找更高的剂量和容量(≥2 mL),有必要更好地了解影响皮下注射疼痛的多种交织因素。作为 SC 药物开发& 给药联盟的优先事项,本手稿从三个方面全面回顾了已发表文献中导致 SC 注射疼痛/不适的已知属性:(1)导致身体疼痛的设备和给药因素,(2)引发疼痛反应的制剂因素,以及(3)影响疼痛感觉的人为因素。利用联盟的集体专业知识,我们对可能影响 SC 注射疼痛的比较因素和相互依存因素进行了评估。此外,我们还提供了专家见解和未来展望,以填补已确定的知识空白,帮助推进以患者为中心、耐受性良好的大剂量/大容量皮下注射给药解决方案的开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
28.10
自引率
5.00%
发文量
294
审稿时长
15.1 weeks
期刊介绍: The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery. In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.
期刊最新文献
Editorial Board Preface: RNA delivery technologies: From concept toward the clinic Delivery and kinetics of immersion optical clearing agents in tissues: Optical imaging from ex vivo to in vivo Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids Corrigendum to “Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration” [Adv. Drug Deliv. Rev. 209 (2024) 115328]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1